Tesamorelin (10 mg) + Ipamorelin (3 mg)

Tesamorelin (10 mg) + Ipamorelin (3 mg) is a dual-peptide research formulation combining a growth hormone–releasing hormone (GHRH) analogue with a selective ghrelin receptor agonist. This combination is studied for its potential to stimulate endogenous growth hormone (GH) release through complementary physiological pathways. At Regena Peptides, this formulation supports laboratory research into endocrine signaling, metabolic regulation, and GH secretion dynamics.
Tesamorelin acts on GHRH receptors to promote GH release, while Ipamorelin selectively activates ghrelin (GHS-R) receptors, making this combination useful in research models evaluating synergistic hormone response.
Research Applications
Investigation of synergistic GH release via GHRH and ghrelin receptor pathways
Studies on metabolic regulation and endocrine system interactions
Exploration of pulsatile GH secretion and feedback mechanisms
Evaluation of combined peptide effects on growth hormone signaling
Reconstitution Instructions
Reconstitute with bacteriostatic (BAC) water
Store refrigerated after reconstitution
Handle under sterile laboratory conditions
Note: For laboratory research purposes only. Not intended for human or veterinary use.